Value proposition
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.
For more information, visit ipsen.com.
Pauta exclusiva para México:
Clave de Autorización COFEPRIS: 243300201B1962
CONSULTE A SU MÉDICO.
Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, and Primary CareOriginal language
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.
For more information, visit ipsen.com.
Pauta exclusiva para México:
Clave de Autorización COFEPRIS: 243300201B1962
CONSULTE A SU MÉDICO.
Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care
Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care
https://www.ipsen.com/
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | IDA Ireland International Trade and Development | Other 16 Feb 2022 | | |